Epigenetics of Urological Cancers

The major urological cancers comprise prostate adenocarcinoma, urinary bladder (or upper urinary tract) carcinoma, renal cell carcinoma, testicular cancer and penile carcinoma, in this order of incidence, each with various histological and molecular subtypes [...].

[1]  W. Schulz,et al.  The histone demethylase UTX/KDM6A in cancer: Progress and puzzles , 2019, International journal of cancer.

[2]  P. Guldberg,et al.  DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies , 2019, International journal of molecular sciences.

[3]  J. Raman,et al.  Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems , 2019, International journal of molecular sciences.

[4]  N. Maitland,et al.  Epigenetic Control of Gene Expression in the Normal and Malignant Human Prostate: A Rapid Response Which Promotes Therapeutic Resistance , 2019, International journal of molecular sciences.

[5]  K. Köhrer,et al.  HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition , 2019, International journal of molecular sciences.

[6]  A. Scorilas,et al.  Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer , 2019, International journal of molecular sciences.

[7]  K. D. Sørensen,et al.  Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer , 2019, International journal of molecular sciences.

[8]  K. D. Sørensen,et al.  5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors , 2019, International journal of molecular sciences.

[9]  H. Schorle,et al.  Epigenetic drugs and their molecular targets in testicular germ cell tumours , 2019, Nature Reviews Urology.

[10]  L. Looijenga,et al.  Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic , 2019, International journal of molecular sciences.

[11]  R. Henrique,et al.  Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer , 2019, International journal of molecular sciences.

[12]  W. Rathmell,et al.  Epigenetic modifiers: activities in renal cell carcinoma , 2018, Nature Reviews Urology.

[13]  P. Jin,et al.  Developing DNA methylation-based diagnostic biomarkers. , 2018, Journal of genetics and genomics = Yi chuan xue bao.

[14]  W. Schulz,et al.  HDACs and HDAC Inhibitors in Urothelial Carcinoma - Perspectives for an Antineoplastic Treatment. , 2017, Current medicinal chemistry.